Abstract
Objectives
Study was conducted to determine acceptability, efficacy, safety, return of fertility with Implanon.
Methods
Volunteers having regular menstruation, requiring spacing formed study population. Implanon was inserted within 5 days of LMP or concurrent with MTP. Woman was asked to record bleeding pattern, side effects. Implanon duration was 3 years but Implanon was removed before, if patient wanted pregnancy/for side effects. Subjects who did not adopt family planning method after removal were followed up for return of ovulation and pregnancy.
Results
200 subjects were enrolled (160 within 5 days of LMP, 40 concurrent with MTP). 74 implanon removals were done. (16 after tenure completion, 58 for other reasons.) 16% cases discontinued implanon for polymenorrhagia, 10% for irregular bleeding, 4.5% for amenorrhea. There was no failure of implanon. 40% had return of ovulation within one month, 95.8% conceived within 12 months.
Conclusions
Implanon is safe, effective, well accepted method of contraception.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Merki Feld GS, Imthurn B, Seifert B. Effects of the progestagen-only contraceptive Implant Implanon((R)) on cardiovascular risk factors. Clin Endocrinol (Oxf). 2008;68(3):355–60.
Wechselberger G, Wolfram D, Pulzl P, et al. Nerve injury caused by removal of an implantable hormonal contraceptive. Am J Obstet Gynecol. 2006;195:323–6.
Osman N, Dinh A, Durbert T, et al.. A new cause for iatrogenic lesion of the ulnar nerve at the arm: contraceptive hormonal implant. Report of two cases. Chir Main. 2005;24:181–3.
Harrrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception. 2005;71:306–8.
Agrawal A, Robinson C. Spontaneous snapping of an Implanon in two halves in situ. J Fam Plann Reprod Health Care. 2003;29:238.
Lakha F, Glasier AF. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception. 2006;74:287–9.
Gezginc K, Belci O, Karatayli R, et al. Contraceptive efficacy, side effects of implanon(R). Eur J Contracep Reprod Health Care. 2007;12:362–5.
Hidalgo MM, Lisondo C, Juliato CT, et al. Ovarian cysts in users of Implanon, Jadelle subdermal contraception implants. Contraception. 2006;73:532–6.
Hamontri S, Weerkul W. Implanon failure. J Med Assoc Thai. 2007;90:381–3.
Mansour M, Louis-Sylvestre C, Paniel BJ. Ectopic pregnancy with etonogestrel contraceptive implant (Implanon): first case. J Gynecol Obstet Biol Reprod (Paris). 2005;34:608–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhatia, P., Nangia, S., Aggarwal, S. et al. Implanon: Subdermal Single Rod Contraceptive Implant. J Obstet Gynecol India 61, 422–425 (2011). https://doi.org/10.1007/s13224-011-0066-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-011-0066-z